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ABSTRACT: 
OBJECTIVES: 
To determine correlation of zero coronary artery calcium score (CACS) with non-significant coronary artery 
stenosis by using computed tomography coronary angiography (CTCA).  
METHODOLOGY: 
62 patients with suspected coronary artery disease (CAD) underwent CACS test and CTCA from April 2018 to 
November 2020. Patients were examined with 160 slice multidetector CT and grouped according to their age, 
gender, CACS, and maximum coronary luminal stenosis. CACS was assessed using Agatston scoring and degree 
of stenosis was assessed by automatic software and severity was scored according to CAD-RADS. The correlation 
between these two main variables was calculated using Spearman rank correlation.  
RESULTS: 
The 62 patients were divided into four groups according to CACS, using the Agatston Unit (AU). Group 1; 0 AU 
(41 patients, 66.13%), Group 2; 1-100 AU (13 patients, 20.97%) Group 3; 101-400 AU (4 patients, 6.45%), 
Group 4; 401-1000 AU (4 patients, 6.45%). In 41 patients with zero calcium score (32 males and 9 females), 38 
patients (92.68%) were found to have no coronary artery stenosis, 2 patients (4.87%) had mild coronary artery 
stenosis and 1 patient (2.43%) had moderate coronary artery stenosis. Total 35 patients presented for screening 
purpose out of which 25 (71%) had zero calcium score and no significant coronary artery disease.  
CONCLUSION: 
In high risk patients, zero calcium score excludes significant coronary artery stenosis (50%), hence coronary 
calcium score is a good screening tool before subjecting patients to coronary angiography. 










Cardiovascular disease is one of the leading causes 
of death worldwide and coronary artery disease 
(CAD) accounts for half of all such deaths1,2. 
According to the 2017 National Health Interview 
Survey in USA, the age-adjusted prevalence of all 
types of heart disease was 10.6%; the corresponding 
age-adjusted prevalence of heart disease among 
whites, blacks, Hispanics, and Asians was 11.0%, 
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9.7%, 7.4%, and 6.1%, respectively3. A study 
conducted in Pakistan, comprising 2000 subjects 
showed 125 subjects (6.25%) with documented 
ischemic heart disease (IHD). The disease burden of 
IHD was therefore estimated as 5.09375 million 
with this prevalence4. Coronary artery calcification 
is a direct result of atherosclerosis. Non-invasive 
coronary artery imaging with computed tomography 
coronary angiography (CTCA) is a highly evolved 
method for the management of patients suspected of 
having coronary artery disease (CAD)5. Agatston et 
al developed the “Agatston score” which is currently 
the standard for measuring CACS6. The Agatston 
score has been shown to be related to the number of 
stenosed vessels determined by coronary 
angiography7. Coronary calcium is the result of 
mural atheromatous plaque except for patients with 
renal failure, who may also have medial 
calcification. Japanese researchers confirmed that an 
elevated CACS determined by using CTCA is an 
independent predictor of mid-to long-term 
cardiovascular mortality and morbidity in patients 
that are suspected of having CAD8. The 
recommendation of CACS by unenhanced CT as an 
initial diagnostic test, in a rapid access chest pain 
clinic (RACPC), for patients with stable chest pain 
has been tested prospectively by Yerramasu et al  In 
the patients with zero CACS only 1.5% had 
obstructive CAD and only 0.8% underwent 
revascularization. It was concluded that in patients 
with stable chest pain symptoms and low likelihood 
of CAD the absence of obstructive CAD can be 
safely predicted by the absence of detectable 
coronary calcification in an unenhanced CT. 
Patients with CACS of >400 AU were found to have 
a high prevalence of obstructive CAD and further 
investigation in the form of invasive coronary 
angiography or functional imaging were considered 
to be more suitable rather than CTA. These results 
are in line with the NICE guidelines for the 
investigation of stable chest pain9. CACS has been 
found to help in risk classification in patients with 
chest pain, even in the absence of prior risk factor 
screening10. Additionally CACS can identify 
patients in whom interventional angiography might 
be a better option, as the final decision regarding 
CAD management cannot be made on CTA11. The 
aim of this study was to determine whether zero 
calcium score could exclude significant plaque 
disease and to determine the correlation between 
coronary calcium score and maximum coronary 
luminal stenosis in the evaluation of CAD and 




This was a cross-sectional descriptive study carried 
out from April 2018 to November 2020, in Lady 
Reading Hospital Peshawar. All the Subjects were 
referred for CTA by their physicians from hospital 
OPD and from the private sector. The sampling 
technique was non-probability consecutive 
sampling. All the included patients were 
asymptomatic and sent for screening purposes as per 
inclusion criteria. Patients were evaluated by their 
physician regarding high risk for CVD according to 
Framingham risk score which included age, gender, 
systolic BP, high cholesterol, smoking and the 
presence of diabetes. Patients who had undergone 
percutaneous or surgical myocardial 
revascularization, patients with history of acute 
coronary syndrome or cardiomyopathy of ischemic 
cause and heart rate >70 with optimal beta blocker 
were excluded. The study was approved by the 
research and ethical committee of the hospital. 
CCTA of coronary arteries were performed using a 
160-slice multi-slice CT scanner (Toshiba model 
cxxg-012a, prime Aquilion Japan Aquilion 64™-
Toshiba™ Medical Systems). An oral beta blocker, 
metoprolol 50 mg, was administered 30 minutes 
before the test in patients with sinus rhythm and 
heart rate (HR) >70 bpm to bring it down to less 
than 70 bpm. The study was conducted in two 
phases: in the first phase, CS was determined by the 
Agatston score with non-contrast computed 
tomography using longitudinal scan coverage from 
the level of the tracheal bifurcation to the lower 
border of cardiac silhouette, including the 
diaphragm for evaluation of the whole cardiac area. 
A field of view (FOV) of 200 mm, slice thickness of 
2.5-3 mm and interval 1.25-1.5 mm, 2x32x0.6 mm 
collimation, rotation time of 350 msec and tube 
current up to 350-450 mAs was used.  Calcification 
was defined as the presence of a lesion with an area 
greater than 1 mm, and peak intensity equal to or 
greater than 130 Hounsfield Units (HU), which was 
automatically identified and marked with color by 
the software. In the second phase, CCTA was 
performed using the same CACS parameters for 
FOV construction, voltage 120 kVp, and 400 mAs. 
Up to 1.5mL/kg iopamidol, which is a nonionic and 
iodinated contrast, was administered intravenously 
to patients at concentrations of 350-370 mg/mL and 
rate of 4.5-5.5 mL/s (Ultravist® 370, Bayer Health 
Care and Pharmaceuticals). Images were initially 
reconstructed at the mid-diastolic phase (70% of R-
R interval) of the cardiac cycle. Additional 
reconstruction windows were constructed after 
examination by using maximum intensity projection 
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and volume rendering technique. Images were sent 
to the workstation for analysis of coronary arteries 
by radiologists having level 1 and level 2 UK 
accreditation. The degree of coronary luminal 
narrowing was measured both by automatic 
(software) and manual method by calculating the 
area of the narrowest part of the lumen in relation to 
the area of the lumen immediately distal to the same 
segment. Coronary stenosis severity was scored 
qualitatively according to CAD-RADS™ i.e. 
minimal <25%, mild 25-49%, moderate 50-69%, 
severe 70-99%, and occluded 100%. Significant 
stenosis was defined as ≥50% of the luminal 
narrowing12. All the patients‟ information including 
name, age, gender, chief complaints (chest pain, 
dyspnea) were recorded. Data was entered and 
analyzed in statistical software SPSS (version 23). 
Mean and standard deviation was calculated for 
continuous variables i.e., age, and frequencies and 
percentages were calculated for categorical variables 
i.e., gender, coronary calcium score and coronary 
artery stenosis. Correlation between calcium score 
and coronary artery stenosis was calculated using 
Spearman rank correlation and p-value of less than 
0.01 was considered significant. 
In the study period from April, 2018 to November 
2020, a total of 62 patients with mean age of 49±3 
years were subjected to CACS examination in Lady 
Reading Hospital Peshawar. Patients were divided 
into four groups according to CACS using the 
Agatston unit (AU). Group 1 included 41 patients 
(66.13%) with 0 calcium score, 13 patients 
(20.13%) in Group 2 with calcium score between 1-
100 AU, 4 patients (6.45%) in Group 3 with CACS 
101-400 AU and 4 patients (6.45%) in Group 4 with 
CACS 401-1000 AU. The associated degree of 
stenosis in the coronary bed is cross tabulated in 
Table 1. In 41 patients with zero calcium score 
(78% male, 22% female), 38 patients (92.68%) were 
found to have no coronary artery stenosis, 2 patients 
(4.87%) had mild coronary artery stenosis and 1 
patient (2.43%) had moderate coronary artery 
stenosis. A total of 35 patients presented for 
screening purpose out of which 25 (71%) were 
having zero calcium score and no significant 
coronary artery disease. Result of Spearman‟s rank 
correlation indicated that there was a strong 
correlation between calcium score and coronary 
artery luminal stenosis (rs) [62]=0.872, p <0.001. 
 
RESULTS :  
Table 1: Calcium Score  Vs.  Luminal Stenosis  
 
Coronary Calcium Score  
                       Coronary Luminal Stenosis  
 
Normal  Minimal  Mild  Moderate  Severe  Total  



























































The use of CAC score in asymptomatic subjects at 
intermediate risk is considered appropriate and is 
recommended as evidenced by international 
consensus statements like 2010 ACCF/SCCT/ACR, 
2014 ACR. The risk assessment was done using 
traditional clinical stratification methods, such as the 
Framingham risk score1. CTCA has proven to have 
a higher negative predictive value for CAD than 
stress echocardiography. However, a normal SE and 
CAC score of zero excludes obstructive CAD (NPV 
100%) and any CAD in 92% of the patients. CT 
calcium scoring adds incremental risk stratification, 
especially in patients with low Framingham score13. 
A meta-analysis done by Sarwar et al published in 
2009,14 which included 13 studies with a collective 
 
total of 29,312 patients showed that a cardiovascular 
event occurred in 0.47% of the patients with a zero 
CACS and in those with a positive score 4.14% had 
such an event, this corresponds to a relative risk of 
0.15 (95% CI: 0.11-0.21; p <0.001). Regarding 
significant stenosis on coronary angiography in 
patients with a CAC score of zero, the same meta-
analysis included 10,355 symptomatic patients 
undergoing catheterization due to suspected CAD or 
acute coronary syndrome. A stenosis of >50% was 
observed in 56% of the patients, of whom 98% had 
a positive CAC score i.e. 2% had zero calcium 
score. This data, taken together, shows that a 
positive CAC score, as a predictor of stenosis >50%, 
has a sensitivity of 98%, a specificity of 40%, a 
negative predictive value (NPV) of 93%, and a 
positive predictive value (PPV) of 68%10. Based on 
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this high NPV, some authors suggest that patients 
with a CAC score of zero would not require further 
ancillary examinations1. In a study conducted by 
Moradi et al in Iran, out of the 385 patients with a 
zero calcium score, 4.2% had atherosclerotic 
plaques, and only 1.6% had significant (>50%) 
coronary stenosis, and 2.6% had no significant 
(<50%) coronary stenosis, with hyperlipidemia, 
diabetes and smoking as significant associations15. 
There have been a few studies in which a higher 
percentage of patients with zero CS were found to 
have obstructive disease. In a study by Akram et al 
it was shown that symptomatic subjects and those 
>45 years of age had atherosclerotic plaque with 
zero CS (8.4%)16. In an original study done in 
Brazil, the main finding was that there was a 
considerable presence (9.3%) of obstructive (≥50%) 
coronary atherosclerotic plaques in patients with 
zero CS. However, there were clinical features 
found to be associated with this high percentage 
along with alcohol consumption and absence of 
obesity17. A study conducted in Peshawar showed 
about 9.3% of patients having significant coronary 
stenosis with zero calcium score in patients having 
atypical chest pain or equivocal result on ETT18, 
while our study showed 2.4% patients having 
significant stenosis with zero score. The difference 
in the results from our study and some of the studies 
might be due to the fact that the majority of our 
patients were asymptomatic and were sent for 
screening purposes. Our results are in accordance 
with international studies i.e. 2% in Neves et al1, 
0.3% in Rosen et al19 and 0.6% in Iwasaki et al20. 
Therefore, it can be safely concluded that zero 
calcium score obviates the need for more invasive 




CACS as a screening tool for asymptomatic patients 
is very scarcely advised due to ionizing radiation 
and along with that, our study started in April 2018 
and continued through the first year of COVID 
lockdown. Later it had to be terminated due to even 
lesser patient flow in the pandemic, so the number 





In high-risk asymptomatic patients, zero calcium 
score nearly excludes significant coronary artery 
(50% luminal stenosis), hence coronary calcium 
score is a good screening tool before subjecting 
patients to more invasive coronary angiography. 
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